Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer.
暂无分享,去创建一个
D W Hillman | J. Cheville | M. Blute | T. Pisansky | S. Schild | R. Myers | M L Blute | S. Buskirk | R. Myers | R P Myers | T M Pisansky | J C Cheville | S E Schild | S J Buskirk | D. Hillman | T F Kozelsky | R G Ferrigni | R. Ferrigni | M. Blute | T. Kozelsky
[1] S. Levitt,et al. Delayed/salvage radiation therapy in patients with elevated prostate specific antigen levels after radical prostatectomy: A long term follow‐up , 1996 .
[2] D. Cox. Regression Models and Life-Tables , 1972 .
[3] R. Parker,et al. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy. , 1998, The cancer journal from Scientific American.
[4] V. Hárs,et al. Postoperative prostate-specific antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical prostatectomy. , 1996, Urology.
[5] M. Kattan,et al. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] P. Lange,et al. Prostate specific antigen and local recurrence after radical prostatectomy. , 1990, The Journal of urology.
[7] T. Stamey,et al. Biological determinants of cancer progression in men with prostate cancer. , 1999, JAMA.
[8] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[9] A. Zietman,et al. Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. , 1997, International journal of radiation oncology, biology, physics.
[10] R W Veltri,et al. Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy. , 1999, Urology.
[11] G. Murphy,et al. National patterns of prostate cancer treatment by radical prostatectomy: results of a survey by the American College of Surgeons Commission on Cancer. , 1994, The Journal of urology.
[12] G. Farrow,et al. Pathologic differentiation and prognosis of prostatic carcinoma. , 1969, JAMA.
[13] W. Catalona,et al. Clinical and pathological characteristics, and recurrence rates of stage T1c versus T2a or T2b prostate cancer. , 1999, The Journal of urology.
[14] Pcs Consensus Committees. 1996 Decision Trees and Management Guidelines. , 1997, Seminars in radiation oncology.
[15] S. Schild,et al. The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy. , 1996, The Journal of urology.
[16] Richard D. Williams,et al. Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] G. Montana,et al. The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen. , 1995, International journal of radiation oncology, biology, physics.
[18] M. Bagshaw. Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer , 1998, International journal of radiation oncology, biology, physics.
[19] N. Sanfilippo,et al. Preirradiation PSA predicts biochemical disease-free survival in patients treated with postprostatectomy external beam irradiation. , 1997, International journal of radiation oncology, biology, physics.
[20] J. Fowler,et al. Variable histology of anastomotic biopsies with detectable prostate specific antigen after radical prostatectomy. , 1995, The Journal of urology.
[21] J. Forman,et al. THERAPEUTIC IRRADIATION FOR PATIENTS WITH AN ELEVATED POST-PROSTATECTOMY PROSTATE SPECIFIC ANTIGEN LEVEL , 1997 .
[22] E. Bergstralh,et al. Comparison of clinically nonpalpable prostate-specific antigen-detected (cT1c) versus palpable (cT2) prostate cancers in patients undergoing radical retropubic prostatectomy. , 1999, Urology.
[23] J. Fowler,et al. Original Articles: Prostate Cancer: Variable Histology of Anastomotic Biopsies With Detectable Prostate Specific Antigen After Radical Prostatectomy , 1995 .
[24] M. Dauge,et al. Effect of radiation therapy after radical prostatectomy on serum prostate-specific antigen measured by an ultrasensitive assay. , 1995, Urology.
[25] W. Catalona,et al. Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment. , 1994, The Journal of urology.
[26] P. Unger,et al. Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high-risk prostate cancer. , 1997, Journal of the National Cancer Institute.
[27] P. Carroll,et al. Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. , 1996, Urology.
[28] J. Cadeddu,et al. Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. , 1998, The Journal of urology.
[29] M. Manyak,et al. (111) INDIUM-CAPROMAB PENDETIDE IN THE EVALUATION OF PATIENTS WITH RESIDUAL OR RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY , 1998 .